Visit

1 Dec

2016

IP lawyer: Amped-up protection on the cards for recombinant DNA products

Australian patent authorities continue to wrestle with the treatment of gene-related inventions. A new ruling may extend the life of patents covering medicines made with recombinant DNA technology

Enter your details below to log into your account.

Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.

TAGS

Litigation, Patents, Strategy, Transactions, Life Sciences, Asia-Pacific, Australia

Twitter

29 Oct 2020

@IAM_magazine Interesting. Although the USPTO Director is a political appointee, it is very unusual to see such an overtly politi… https://t.co/hhsB2wD487 Read more

29 Oct 2020

@IAM_magazine Deutsche Telekom looks to bring auctions back to the patent market with December portfolio sale… https://t.co/RfjR9oTyqn Read more

29 Oct 2020

@IAM_magazine Multi-billion dollar Bayer deal shows growing attraction of gene and cell therapy assets: https://t.co/l3OpUq8avd https://t.co/77N8FKd7zv Read more

29 Oct 2020

@IAM_magazine UMC will pay the second largest fine in a criminal trade secrets case to move past a damaging dispute with Micron a… https://t.co/pLJuwkBGfP Read more

Find an expert

Partner

Seattle WA, United States

Lee & Hayes, PC

View full biography